BCL2 Regulation according to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.

Cancer Res Treat · 2018 · PMC6056973 · PMID 28701032

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

[ 14 ] reported that BCL2 was a strong favorable prognostic factor in those with the luminal A subtype and a marginally significant favorable prognostic factor in patients with the luminal B subtype.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.